Co-production of the ‘My SJS Passport’ to support survivors of Stevens–Johnson syndrome post-diagnosis and beyond: a proof-of-concept study
The study provides the first formal evaluation of the passport and showed that the tool is acceptable, functional and of benefit to the user. Minor barriers to implementation were identified, largely due to the COVID-19 pandemic and, to a lesser extent, the passport design. There is no comparable tool in use; thus, based on these preliminary findings, it is thought that the passport has a valuable role in supporting this underserved population.
Authors
- Tom Lawson (ORCID: https://orcid.org/0009-0007-5804-3942)
- Andrew R. Thompson (ORCID: https://orcid.org/0000-0003-0917-1255)
- Jane Evely
- Munir Pirmohamed (ORCID: https://orcid.org/0000-0002-7534-7266)
- Lucy Hampson
- Jane L. Burns (ORCID: https://orcid.org/0009-0007-3356-9606)
- Anita Hanson (ORCID: https://orcid.org/0000-0002-6089-9631)
- Jennifer Downing (ORCID: https://orcid.org/0000-0001-7691-1167)
- Daniel F. Carr (ORCID: https://orcid.org/0000-0001-8028-4282)
- M P Hill
- Nathan Elsdon
Institutions
- University of Liverpool (GB)
- Aintree University Hospitals NHS Foundation Trust (GB)
- National Institute for Health and Care Research (GB)
- Health Awareness (United States) (US)
- University Hospitals Plymouth NHS Trust (GB)
Publication Details
- Journal
- Clinical and Experimental Dermatology
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1093/ced/llaf088
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Liverpool University Hospitals NHS Foundation Trust